CoChat

Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2

Open access

The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.

Abstract

The recently emerged COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has adversely affected the whole world. As a significant public health threat, it has spread worldwide. Scientists and global health experts are collaborating to find and execute speedy diagnostics, robust and highly effective vaccines, and therapeutic techniques to tackle COVID-19. The ocean is an immense source of biologically active molecules and/or compounds with antiviral-associated biopharmaceutical and immunostimulatory attributes. Some specific algae-derived molecules can be used to produce antibodies and vaccines to treat the COVID-19 disease. Algae have successfully synthesized several metabolites as natural defense compounds that enable them to survive under extreme environments. Several algae-derived bioactive molecules and/or compounds can be used against many diseases, including microbial and viral infections. Moreover, some algae species can also improve immunity and suppress human viral activity. Therefore, they may be recommended for use as a preventive remedy against COVID-19. Considering the above critiques and unique attributes, herein, we aimed to systematically assess algae-derived, biologically active molecules that could be used against this disease by looking at their natural sources, mechanisms of action, and prior pharmacological uses. This review also serves as a starting point for this research area to accelerate the establishment of anti-SARS-CoV-2 bioproducts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules26082134

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A schematic of seaweed polysaccharides (SP) used as notable biotherapeutic agents against SARS-CoV-2. The figure was created with the “BioRender.com” template and exported under the terms of premium subscription.
Figure 1 A schematic of seaweed polysaccharides (SP) used as notable biotherapeutic agents against SARS-CoV-2. The figure was created with the “BioRender.com” template and exported under the terms of premium subscription.CC BY · PubMed Central
Figure 2 The putative association between ACE2 shedding after SARS-CoV-2 infection. Reprinted from Viana et al. [56] with permission from Elsevier. Copyright 2021, Elsevier. License Number: 4993920853888.
Figure 2 The putative association between ACE2 shedding after SARS-CoV-2 infection. Reprinted from Viana et al. [56] with permission from Elsevier. Copyright 2021, Elsevier. License Number: 4993920853888.CC BY · PubMed Central
Figure 3 A schematic of the COVID-19 viral immune response and the targets of common dermatologic immunomodulators. The SARS-CoV-2 virus attacks host cells by binding to their receptors present in the cell membrane. Upon the first infection, lung epithelial cells become the primary target, where the receptor-binding domain of the virus spikes binds to ACE2 receptors. SARS-CoV-2 infects the human lung epithelium via the receptor ACE2. Viral RNA activates endosomal and cytoplasmic sensors (TLR3/7 and MAVS, respectively). These receptors activate interferon regulatory factors (IRFs) and NFkB to induce inflammatory cytokines, including interferons (IFN). CD8 T cells induce apoptosis after the recognition of antigens on infected cells. Conversely, activated B cells differentiate into plasma cells that produce antibodies important for neutralizing viruses. This figure was created with the “BioRender.com” template and exported under the terms of premium subscription.
Figure 3 A schematic of the COVID-19 viral immune response and the targets of common dermatologic immunomodulators. The SARS-CoV-2 virus attacks host cells by binding to their receptors present in the cell membrane. Upon the first infection, lung epithelial cells become the primary target, where the receptor-binding domain of the virus spikes binds to ACE2 receptors. SARS-CoV-2 infects the human lung epithelium via the receptor ACE2. Viral RNA activates endosomal and cytoplasmic sensors (TLR3/7 and MAVS, respectively). These receptors activate interferon regulatory factors (IRFs) and NFkB to induce inflammatory cytokines, including interferons (IFN). CD8 T cells induce apoptosis after the recognition of antigens on infected cells. Conversely, activated B cells differentiate into plasma cells that produce antibodies important for neutralizing viruses. This figure was created with the “BioRender.com” template and exported under the terms of premium subscription.CC BY · PubMed Central
Figure 4 An array of algae-based antioxidants. The inner circle shows the diversity of biologically active antioxidants produced in a marine environment. The outer circle represents their novel therapeutic and biomedical potentialities. Reprinted from Bilal and Iqbal [101] with permission from Elsevier. Copyright 2021 Elsevier B.V. License Number: 4982940408845.
Figure 4 An array of algae-based antioxidants. The inner circle shows the diversity of biologically active antioxidants produced in a marine environment. The outer circle represents their novel therapeutic and biomedical potentialities. Reprinted from Bilal and Iqbal [101] with permission from Elsevier. Copyright 2021 Elsevier B.V. License Number: 4982940408845.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. 2014, Antiviral activity of an aqueous extract from the red alga Laurencia obtusa against influenza A and B viruses, Rev. Cuba. Med. Trop., 66, 273
  2. Sundararaj, 2020, Algae: A potential source to prevent and cure the novel coronavirus–A review, Int. J. Emerg. Technol., 11, 479
  3. Nikunj, 2020, Lensi P, Richa P, haresh P, Red algae derived phycocompounds as an inhibitors of SARS-CoV-2, J. Interdiscip. Cycle Res., 12, 662

Cited by

See all 72

Metadata

Authors
Alam, M. A., Parra-Saldivar, R., Bilal, M., Afroze, C. A., Ahmed, M. N., Iqbal, H. M. N., & Xu, J.
Affiliations
  • Zhengzhou University (CN)
  • Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey 64849, Mexico
  • Huai'an University (CN)
  • University of Development Alternative (BD)
  • Biotechnology & Natural Medicine Division, TechB Nutrigenomics, Dhaka 1209, Bangladesh
  • Tecnológico de Monterrey (MX)
Corresponding author
  • Iqbal, Hafiz M.N.
  • Xu, Jingliang
Venue
Molecules
Publisher
MDPI AG
Published
2021-04-08
Volume
26
Issue
8
Pages
2134
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3147076663
Cited by
69
References
116
Citations by year
2026: 3 · 2025: 9 · 2024: 7 · 2023: 13 · 2022: 31 · 2021: 6
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Consejo Nacional de Ciencia y Tecnología (735340, CVU: 735340)
  • Sistema Nacional de Investigadores (CVU: 735340, 735340)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
Keywords
SARS-CoV-2, COVID-19 pandemic, antiviral activity, marine bioproducts
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Phaeophyceae, Chlorophyta, Rhodophyta, Antiviral Agents, Carrageenan, Humans, Polysaccharides, Lectins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.